Biopharmaceutical company Seres Therapeutics, Inc. recently announced the implementation of a series of strategic adjustments aimed at extending its corporate operating cycle.

Jensen Huang has recently made consecutive public statements claiming that AI development does not require new laws or regulations, characterizing the opposition between innovation and safety as a "false choice." He publicly appeared with Trump, forming a stark contrast to the stance of Dario Amodei, Sam Altman, and Elon Musk, who have called for coordinated efforts to slow down AI research. However, Nvidia’s business interests are closely tied to the pace of investment in AI infrastructure.